Pfizer JKI 10 Pill - blue round, 10mm
Generic Name: tofacitinib
Pill with imprint Pfizer JKI 10 is Blue, Round and has been identified as Xeljanz 10 mg. It is supplied by Pfizer Inc.
Xeljanz is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis; Polyarticular Juvenile Idiopathic Arthritis; Ulcerative Colitis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer JKI 10
Xeljanz
- Generic Name
- tofacitinib
- Imprint
- Pfizer JKI 10
- Strength
- 10 mg
- Color
- Blue
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-1002
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
croscarmellose sodium,
magnesium stearate,
titanium dioxide,
triacetin,
polyethylene glycol 3350,
hypromellose 2910 (6 mPa.s),
FD&C Blue No. 1,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about Xeljanz (tofacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (144)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.